Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Publication year range
1.
Respir Care ; 60(9): 1238-46, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26106207

ABSTRACT

BACKGROUND: In vivo deposition studies of aerosol administration during noninvasive ventilation (NIV) are scarce in the literature. The aim of this study was to compare radioaerosol pulmonary index and radioaerosol mass balance in the different compartments (pulmonary and extrapulmonary) of radio-tagged aerosol administered using vibrating mesh nebulizers and conventional jet nebulizers during NIV. METHODS: This was a crossover clinical trial involving 10 healthy subjects (mean age of 33.7 ± 10.0 y) randomly assigned to both treatment arms of this study: group 1 (NIV + vibrating mesh nebulizer, n = 10) and group 2 (NIV + jet nebulizer, n = 10). All subjects inhaled 3 mL of technetium-99m diethylenetriaminepentaacetic acid (25 mCi) and 0.9% saline solution via vibrating mesh and jet nebulizers during NIV through a face mask secured with straps while receiving positive inspiratory and expiratory pressures of 12 and 5 cm H2O, respectively. Scintigraphy was performed to count radioaerosol particles deposited in the regions of interest to determine radioaerosol mass balance from the lungs, upper airways, stomach, nebulizer, ventilator circuit, inspiratory and expiratory filters, and mask as a percentage. RESULTS: Vibrating mesh nebulizers deposited 972,013 ± 214,459 counts versus jet nebulizer with 386,025 ± 130,363 counts (P = .005). In a determination of mass balance, vibrating mesh nebulizers showed a higher deposition of inhaled radioaerosol compared with jet nebulizers (23.1 ± 5.8% vs 6.1 ± 2.5%, P = .005) and a higher proportion of radioaerosol deposited into the lungs (5.5 ± 0.9% versus 1.5 ± 0.6%, respectively, P = .005). The residual drug volume was lower with vibrating mesh nebulizers (5.1 ± 1.5%) compared with jet nebulizers (41.3 ± 4.2%, P = .005). CONCLUSIONS: During NIV in healthy subjects, vibrating mesh nebulizers delivered > 2-fold more radiolabeled drug into the respiratory tract compared with conventional jet nebulizers. Additional studies are recommended in subjects with asthma, COPD, bronchiectasis, and cystic fibrosis to better understand differences in both aerosol delivery and response. (ClinicalTrials.gov registration NCT01889524.).


Subject(s)
Nebulizers and Vaporizers , Noninvasive Ventilation/instrumentation , Radiopharmaceuticals/administration & dosage , Technetium Tc 99m Pentetate/administration & dosage , Adult , Aerosols , Cross-Over Studies , Female , Healthy Volunteers , Humans , Lung/drug effects , Male , Noninvasive Ventilation/methods
2.
Respir Care ; 59(3): 328-33, 2014 Mar.
Article in English | MEDLINE | ID: mdl-23920214

ABSTRACT

BACKGROUND: The Acapella device produces high-frequency oscillations and positive expiratory pressure to promote bronchial secretion clearance. Its performance during aerosol delivery has not been described. We evaluated the effect of nebulizer and Acapella configuration on pulmonary deposition of radio-tagged aerosol in healthy subjects. METHODS: Ten healthy male subjects (mean age 24.4 ± 2.2 y) participated in a crossover study that compared pulmonary delivery of 4 mL of technetium-99m-labeled diethylene triamine penta-acetic acid (25 mCi) and 0.9% saline solution via jet nebulizer. We tested 3 configurations: nebulizer attached to the distal end of the Acapella; nebulizer placed between the mouthpiece and the Acapella; and nebulizer alone (control). With scintigraphy we measured radio-aerosol deposition in 6 lung regions: upper, middle, lower, central, intermediate, and peripheral. RESULTS: Deposition was similar between the right and left lungs, with no significant differences between device configurations. Lung deposition was less with the nebulizer attached to the Acapella than with nebulizer between the mouthpiece and the Acapella (P = .001, for both lungs) or without the Acapella (P = .003 and P = .001 for the right and left lungs, respectively). There was no significant difference between the setup without Acapella and the setup with the nebulizer between the mouthpiece and the Acapella (P = .001, for both lungs). On the vertical axis, deposition was lower with the nebulizer attached to the distal end of the Acapella than with the nebulizer between the mouthpiece and the Acapella (upper region P < .001, middle region P = .001, lower region P = .003), and lower with the nebulizer attached to the distal end of the Acapella than with the setup without Acapella (upper and middle region both P = .001, lower region P = .002), with up to a 3-fold difference in the middle and lower regions. On the central-peripheral axis, deposition was lower with the nebulizer attached to the distal end of the Acapella than with the nebulizer between the mouthpiece and the Acapella (central region P < .001, peripheral region P < .001), and lower with the nebulizer attached to the distal end of the Acapella than with the setup without Acapella (central and peripheral regions both P = .002), with differences of 3-4-fold between the central and peripheral regions. CONCLUSIONS: Placing the nebulizer distal to the Acapella, as recommended by the manufacturer, decreased intrapulmonary deposition, compared to placing the nebulizer between the Acapella and the patient airway, or delivering aerosol without the Acapella in the circuit. (ClinicalTrials.gov NCT01102166).


Subject(s)
Aerosols/administration & dosage , Lung/diagnostic imaging , Nebulizers and Vaporizers , Positive-Pressure Respiration/instrumentation , Adult , Cross-Over Studies , Equipment Design , Humans , Male , Radionuclide Imaging , Young Adult
3.
Respir Care ; 58(2): 241-9, 2013 Feb.
Article in English | MEDLINE | ID: mdl-22781558

ABSTRACT

BACKGROUND: Despite the clinical improvements attributed to noninvasive ventilation (NIV) during asthma crises, and the well established effects of nebulization, there are few studies on the effects of these interventions together. We hypothesized that nebulization coupled to NIV should raise radio-aerosol pulmonary deposition in asthmatics. The aims of this study were to assess the effects of coupling ß-agonist nebulization and NIV during asthma exacerbations on radio-aerosol pulmonary deposition, using scintigraphy and cardiopulmonary parameters, to correlate pulmonary function with radio-aerosol deposition index, radio-aerosol penetration index, and pulmonary clearance. METHODS: In this controlled trial, 21 adults with moderate to severe asthma attack were randomized to a control group (n = 11) or experimental group (NIV + nebulizer group, n = 10). All subjects inhaled bronchodilators for 9 minutes, and after particles were counted with a gamma camera to analyze regions of interest and pulmonary clearance at 0, 15, 30, 45, and 60 min. RESULTS: Breathing frequency (P = < .001) and minute ventilation (P = .01) were reduced, and tidal volume was increased (P = .01) in the NIV + nebulizer group, compared with the control group. The NIV + nebulizer group had improvement from baseline values, compared to the control group in the following parameters: FEV(1) 46.7 ± 0.5% of predicted vs 29.8 ± 8.9% of predicted, P = .02), FVC (41.2 ± 1.5% of predicted vs 23.2 ± 7.1% of predicted, P = .02), peak expiratory flow (67.3 ± 38.3% of predicted vs 26.9 ± 12.1% of predicted, P = .01), and inspiratory capacity (54.9 ± 28.8% of predicted vs 31.2 ± 9.1% of predicted, P = .01). No differences were observed between groups regarding radio-aerosol deposition index or pulmonary clearance. Negative correlations were found between FEV1, forced expiratory flow during the middle half of the FVC maneuver (FEF(25-75%)), inspiratory capacity, and radio-aerosol penetration index. CONCLUSIONS: Coupling nebulization and NIV during asthma exacerbation did not improve radio-aerosol pulmonary deposition, but we observed clinical improvement of pulmonary function in these subjects. (ClinicalTrials.gov registration NCT01012050).


Subject(s)
Adrenergic beta-Agonists/administration & dosage , Asthma/physiopathology , Asthma/therapy , Bronchodilator Agents/administration & dosage , Continuous Positive Airway Pressure , Radiopharmaceuticals , Technetium Tc 99m Pentetate , Adolescent , Adrenergic beta-Agonists/pharmacokinetics , Adult , Aged , Bronchodilator Agents/pharmacokinetics , Female , Forced Expiratory Volume , Humans , Male , Middle Aged , Nebulizers and Vaporizers , Peak Expiratory Flow Rate , Radiopharmaceuticals/pharmacokinetics , Respiratory Rate , Technetium Tc 99m Pentetate/pharmacokinetics , Tidal Volume , Young Adult
4.
Fisioter. pesqui ; 14(1): 29-36, jan.-abr. 2007. graf
Article in Portuguese | LILACS | ID: lil-450881

ABSTRACT

Este estudo visou comparar deposição de aerossol no pulmão mediante o uso de nebulizador ultra-sônico (US), sem e com utilização de válvula de pressão positiva expiratória final (PEEP), comparando ainda duas pressões da válvula, de 5 cmH2O e de 10cmH2O. Para analisar a deposição de aerossol, foram delimitadas regiões de interesse...


This study aimed comparing aerosol deposition into lungs using an ultrasonic (US) nebulizer, with and without using a positive end expiratory pressure (PEEP) valve, also comparing two valve pressures, 5 cmH2O and 10cmH2O. Twelve young healthy volunteers were submitted to Tc99m radioaerosol inhalation generated by nebulizer in three stages:


Subject(s)
Humans , Male , Female , Occupational Diseases/rehabilitation , Exercise Therapy , Rest , Electromyography
5.
Respir Med ; 100(4): 721-8, 2006 Apr.
Article in English | MEDLINE | ID: mdl-16139491

ABSTRACT

UNLABELLED: Nebulization associated with noninvasive ventilation is used in emergency services and intensive care units. PURPOSES: To compare pulmonary radioaerosol deposition during jet nebulization associated to noninvasive ventilation versus spontaneous breathing nebulization; to measure the rate of lung depuration and the correlation between lung deposition, inspiratory flow and tidal volume (V(t)) using scintigraphy. SUBJECTS: Thirteen healthy volunteers (with normal spirometry), mean age (23.3+/-1.49) years, body mass index 21.2+/-2.3 kg/m(2). METHODS: Nebulization was performed in spontaneous breathing and associated with bi-level noninvasive ventilation (inspiratory pressure=12 cm H(2)O, expiratory pressure=5 cm H(2)O). The radioaerosol used in the nebulization was technetium (Tc99m) with diethylene triamine penta acetic acid, generated over a period of 9 min in a jet nebulizer. Analysis was performed through scintigraphy. Statistical analysis was performed by analysis of variance (for repeated measures), Bonferroni method, Student's t-test and Person's correlation. RESULTS: There was a decrease in radioaerosol lung deposition with nebulization associated to noninvasive ventilation (mean counts in spontaneous breathing 200,510+11,012 and mean counts in noninvasive ventilation 106,093+2811 (P<0.001). During spontaneous breathing nebulization there was a significant correlation between V(t) and radioaerosol deposition (r=0.565, P<0.05), also between inspiratory flow and radioaerosol deposition in the lungs (r=0.141, P<0.05). However, there was no correlation between V(t) and pulmonary deposition of radioaerosol in bi-level noninvasive ventilation nebulization (r=0.082). CONCLUSION: During nebulization with noninvasive ventilation in healthy volunteers, there was an increase in V(t) associated to a higher inspiratory flow rate, without resulting in a significant increase in pulmonary radioaerosol deposition.


Subject(s)
Lung/metabolism , Nebulizers and Vaporizers , Respiratory Therapy/methods , Technetium Tc 99m Pentetate/pharmacokinetics , Administration, Inhalation , Adult , Aerosols , Female , Humans , Lung/diagnostic imaging , Male , Radionuclide Imaging , Respiratory Function Tests , Technetium Tc 99m Pentetate/administration & dosage
6.
Physiother Res Int ; 10(4): 182-9, 2005.
Article in English | MEDLINE | ID: mdl-16411613

ABSTRACT

BACKGROUND AND PURPOSE: Patients with chronic obstructive pulmonary disease (COPD) present pulmonary hyperinflation as the main cause of mechanical disadvantages in respiratory muscles. Measurement of the force generated by those muscles is converted into pressure changes. The aim of the present study was to evaluate the maximal inspiratory pressure (MIP) from the residual volume (RV) and from the functional residual capacity (FRC), in patients with COPD, and to determine which pulmonary volume should be used in physiotherapy so as to obtain higher MIP results. METHOD: An investigation of 18 male patients with stable COPD. Patients were examined using a manual vacuometer to measure the MIP of 20 daily manoeuvres. Ten measurements were taken from the RV and 10 from the FRC, taken alternately with an interval of 1 minute between each measurement, for five consecutive days. RESULTS: Increases in MIP were obtained from the RV measurements (mean +/- SE) from 59.7 (+/- 5.2) to 66.6 (+/- 5.3) cm H2O (F(4,64) = 3.34; p < 0.015) and from the FRC measurements, from 55.4 (+/- 4.9) to 64.4 (+/- 4,8) cm H2O (F(4,64) = 6.72; p < 0.001). Post hoc analysis showed an increase, over consecutive days, in both RV and FRC. For FRC, an increase was revealed on the second and third days, a fall was found on the fourth day and a new increase was found on the last day. MIP reached different levels, between RV and FRC, on the first (t = 2.888; p = 0.010) and fourth (t = 2.165; p = 0.045) days. CONCLUSION: In the present study, MIP reached higher levels at FRC during the five days of evaluation, and a learning effect occurred in the patients. Motor units from the respiratory muscles may have been recruited in order to perform the manoeuvres during the days of evaluation. The study suggests that there is good evidence for the use of the FRC as a parameter to find the major MIP value.


Subject(s)
Inhalation , Physical Therapy Modalities , Pulmonary Disease, Chronic Obstructive/physiopathology , Pulmonary Disease, Chronic Obstructive/rehabilitation , Respiratory Muscles/physiopathology , Aged , Analysis of Variance , Functional Residual Capacity , Humans , Male , Residual Volume , Respiratory Function Tests
SELECTION OF CITATIONS
SEARCH DETAIL
...